Minerva Neurosciences, Inc. (NERV)
2.00
-0.12
(-5.66%)
USD |
NASDAQ |
Nov 20, 16:00
2.03
+0.03
(+1.50%)
After-Hours: 20:00
Minerva Neurosciences Cash and Short Term Investments (Annual) : 82.40M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 82.40M |
| December 31, 2024 | 21.46M |
| December 31, 2023 | 41.01M |
| December 31, 2022 | 36.19M |
| December 31, 2021 | 60.86M |
| December 31, 2020 | 25.46M |
| December 31, 2019 | 45.95M |
| December 31, 2018 | 88.10M |
| Date | Value |
|---|---|
| December 31, 2017 | 128.24M |
| December 31, 2016 | 83.06M |
| December 31, 2015 | 32.28M |
| December 31, 2014 | 18.58M |
| December 31, 2013 | 1.818M |
| December 31, 2012 | 0.2003M |
| December 31, 2011 | 0.2089M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Heron Therapeutics, Inc. | 46.63M |
| Tonix Pharmaceuticals Holding Corp. | 207.64M |
| Karyopharm Therapeutics, Inc. | 63.74M |
| Corbus Pharmaceuticals Holdings, Inc. | 163.94M |
| Ocugen, Inc. | 18.57M |